MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Characterizing task-based acoustic variations of vowels in Parkinson’s disease: Preliminary data

    C. Kuo (Harrisonburg, VA, USA)

    Objective: This is a pilot study that examines changes in the acoustic characteristics of vowels across speaking tasks for individuals with Parkinson’s disease (PD). The…
  • 2017 International Congress

    Helicobacter pylori eradication and risk of Parkinson’s disease in patients with peptic ulcers

    Y.-P. Chang, G.-F. Chiu, Y.-H. Chang, D.-C. Wu (Kaohsiung, Taiwan)

    Objective: To observe the effect of Helicobacter pylori eradication on the incidence of Parkinson's disease Background: The prevalence of Helicobacter pylori (H. pylori) is high in Parkinson's disease (PD)…
  • 2017 International Congress

    Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression

    E. Dalle, D. William, M. Musa (Durban, South Africa)

    Objective: The objective of this study was to investigate how fluvoxamine maleate treatment regulates depressive-like symptoms, motor impairments and the expressions of IL-1beta, IL-6, IL-10…
  • 2017 International Congress

    The impact of Parkinson’s disease on faith and spirituality

    A. Weldehana (Addis Ababa, Ethiopia)

    Objective: The objective of the present study is to assess the impact of Parkinson’s disease on faith and spirituality.  Background: There are some controversies on…
  • 2017 International Congress

    Olfaction and gustation in patients with Parkinson’s Disease

    A. Tautscher-Basnett, V. Tomantschger, M. Freimueller (Hermagor, Austria)

    Objective: This study investigates smell and taste function in patients with Parkinson’s Disease (PD). Background: Up to 90% of patients with PD suffer from olfactory…
  • 2017 International Congress

    Neuroanatomical correlates of depressive symptoms in newly diagnosed Parkinson’s disease patients

    S.J. Kim (Busan, Republic of Korea)

    Objective: Depression is the most frequent neuropsychiatric manifestation in Parkinson's disease (PD). Although evidence suggests that depression in PD is related to the degenerative process…
  • 2017 International Congress

    Central Aortic Pressure in Parkinson’s Disease and Levodopa Effect

    M. BALAL, M. DEMIRKIRAN (Adana, Turkey)

    Objective: Central aortic pressure (CAP) is the systolic blood pressure at the root of the aorta. In young people CAP is lower than the peripheral…
  • 2017 International Congress

    Pain and Parkinson’s disease

    H. Wilson, T. Yousaf, G. Pagano, M. Politis (London, United Kingdom)

    Objective: We aimed to explore clinical correlates and risk factors in the development of pain, alongside the relationship between pain and striatal dopaminergic dysfunction in…
  • 2017 International Congress

    Non-motor symptoms in Parkinsons’s disease patients treated with levodopa-carbidopa intestinal gel infusion- the follow up study

    A. Križnar, N. Zupančič Križnar, M. Kramberger, J. Bon, R. Rajnar, L. Ocepek, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: To follow up the effect of continuous levodopa-carbidopa intestinal gel infusion (LCIG) on motor and non-motor symptoms in advanced Parkinson’s disease (aPD). Background: Non-motor…
  • 2017 International Congress

    Association of pain and depression with Parkinson’s disease-osteoarthritis comorbidity.

    A.Q. Rana, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)

    Objective: The goal of this study was to observe if additional pain associated with comorbid symptomatic OA in PD patients is correlated with greater depression…
  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley